In a landmark decision, the Pretoria High Court has given the South African Pharmacy Council (SAPC) the judicial green light to implement its Pharmacy-Initiated Management of Antiretroviral Treatment (PIMART) initiative. This allows specially trained pharmacists to manage and prescribe medicine to patients with HIV and tuberculosis.
Judge Elmarie van der Schyff dismissed an application by a doctors’ organisation, the IPA Foundation, to set aside the programme, stating the need for wider access to first-line ART and TPT therapy on a community level is a “dire need”.
The PIMART training course was created to qualify pharmacists in safely and effectively assisting in providing ART, upon successful completion.
This ruling is in line with the World Health Organization’s vision to promote widely accessible primary health care and recognizes the critical role pharmacies play in meeting healthcare needs, especially during pandemics like COVID-19.
Professor Francois Venter, former President of the Southern African HIV Clinicians Society and current Director of Ezintsha, an HIV research organisation, has emphasized the crucial role of pharmacies and pharmacists in expanding HIV services worldwide.
Let’s celebrate this win.
🚀 Is the non-opioid pain management market on the verge of a strategic shift?
Viatris’ MR-107A-02 shows 73% opioid-free recovery in herniorrhaphy, strong Phase 3 efficacy, and placebo-comparable safety.
With a $45B market at stake, the implications for commercial strategy and payer positioning are significant.
Read our full breakdown—market dynamics, clinical data, and the transformative potential of MR-107A-02.
#SyenzaNews #pharmaceuticals #HealthcareInnovation
🔍 What if we could transform the treatment landscape for chronic Hepatitis Delta Virus (HDV)?
Recent findings from Gilead’s Phase 3 MYR301 study reveal that bulevirtide therapy not only achieves remarkable virologic control during treatment but also sustains that control after therapy cessation for many patients. With a striking 90% of patients remaining undetectable post-treatment, this could signify a major breakthrough in HDV management.
Learn more about how this could reshape patient outcomes and health economics? See full article for all the insights!
#SyenzaNews #HealthcareInnovation #HealthEconomics #MarketAccess
💡 Is prevention really saving us money in healthcare?
In their thought-provoking article, “Can Prevention Save Money?”, Baicker and Chandra challenge the prevailing notion that preventive health measures always reduce costs. They argue that while prevention can enhance health outcomes, it often leads to increased spending upfront, and the key lies in evaluating these programs based on their cost-effectiveness instead of expecting them to save money outright.
Curious about the real financial implications of preventive care? Dive into the full analysis to uncover the nuances!
#SyenzaNews #HealthEconomics #costeffectiveness #healthcarepolicy
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER
